Benefit from adrenocorticotrophin in myasthenia gravis
Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH). The mean duration of benefit was approximately six months. The best results were obtained in patients with a short history of myasthenia. Transient deterioration d...
Tallennettuna:
| Julkaisussa: | J Neurol Neurosurg Psychiatry |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
1974
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC494671/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4365243/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.37.4.412 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|